These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1009 related articles for article (PubMed ID: 17343429)

  • 1. Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?
    Thorne C; Newell ML
    Drug Saf; 2007; 30(3):203-13. PubMed ID: 17343429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues.
    Thorne C; Newell ML
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):425-36. PubMed ID: 15010553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety of antiretroviral drugs in pregnancy.
    Thorne C; Newell ML
    Expert Opin Drug Saf; 2005 Mar; 4(2):323-35. PubMed ID: 15794723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of HIV-infected pregnant women: prevention of virus transmission and adverse effects in mother and child].
    Boer K; Nellen JF; Kreyenbroek ME; Godfried MH
    Ned Tijdschr Geneeskd; 2009; 153():B410. PubMed ID: 19785876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF; Castelo A; Martínez M
    AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial disorders among infants exposed to HIV and antiretroviral therapy.
    Funk MJ; Belinson SE; Pimenta JM; Morsheimer M; Gibbons DC
    Drug Saf; 2007; 30(10):845-59. PubMed ID: 17867723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
    Mofenson LM;
    MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No relation between in-utero exposure to HAART and intrauterine growth retardation.
    Briand N; Mandelbrot L; Le Chenadec J; Tubiana R; Teglas JP; Faye A; Dollfus C; Rouzioux C; Blanche S; Warszawski J;
    AIDS; 2009 Jun; 23(10):1235-43. PubMed ID: 19424054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
    Gibb DM; Kizito H; Russell EC; Chidziva E; Zalwango E; Nalumenya R; Spyer M; Tumukunde D; Nathoo K; Munderi P; Kyomugisha H; Hakim J; Grosskurth H; Gilks CF; Walker AS; Musoke P;
    PLoS Med; 2012; 9(5):e1001217. PubMed ID: 22615543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety of highly active antiretroviral therapy for the HIV-positive pregnant mother and her baby: is 'the more the merrier'?
    Martin F; Taylor GP
    J Antimicrob Chemother; 2009 Nov; 64(5):895-900. PubMed ID: 19706669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
    Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J
    JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn.
    Hernàndez S; Morén C; López M; Coll O; Cardellach F; Gratacós E; Miró O; Garrabou G
    AIDS; 2012 Feb; 26(4):419-28. PubMed ID: 22156962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.
    Townsend CL; Cortina-Borja M; Peckham CS; de Ruiter A; Lyall H; Tookey PA
    AIDS; 2008 May; 22(8):973-81. PubMed ID: 18453857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral therapy in pregnancy: a focus on safety.
    Taylor GP; Low-Beer N
    Drug Saf; 2001; 24(9):683-702. PubMed ID: 11522121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating HIV during pregnancy: an update on safety issues.
    Watts DH
    Drug Saf; 2006; 29(6):467-90. PubMed ID: 16752931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity.
    Ciaranello AL; Seage GR; Freedberg KA; Weinstein MC; Lockman S; Walensky RP
    AIDS; 2008 Nov; 22(17):2359-69. PubMed ID: 18981776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
    Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M;
    JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.